Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate
Open Access
- 1 December 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (12), 2307-2313
- https://doi.org/10.1016/0006-2952(93)90622-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587Biochemical Pharmacology, 1992
- Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse TranscriptaseScience, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Incorporation of 3’-Azido-3’-deoxythymidine into Cellular DNA and Its Removal in a Human Leukemic Cell LineCancer Communications, 1990
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- Inhibition of human immunodeficiency virus reverse transcriptase by 2?,3?-dideoxynucleoside triphosphates: Template dependence, and combination with phosphonoformateVirus Genes, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- RetrovirusesScience, 1988
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986